Drug intelligence / Profile preview

Wenjing Tongluo Paste

Development stage: Unknown
Lead developer: Longhua Hospital Shanghai University of Traditional Chinese Medicine
Administration: Topical

Overview

Wenjing Tongluo Paste is a traditional Chinese medicine (TCM) topical formulation developed by Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine. It is specifically indicated for the treatment of early and middle-stage knee osteoarthritis. The formulation is designed to warm the meridians and unblock the collaterals, which aims to alleviate joint pain, reduce swelling, and improve knee function and quality of life. It is typically administered via external application, often in the form of a Babu (cataplasm) or hydrogel patch, which allows for the sustained release of herbal active ingredients directly to the affected joint.

Other names: Wenjing Tongluo BabuWenjing Tongluo Cataplasm

Beyond the preview

Go deeper on Wenjing Tongluo Paste.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wenjing Tongluo Paste.

Explore the full profile